Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion type Assertion NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_head.
- NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion description "[Furthermore, we compared GPX3 level of expression and methylation status in aggressive phenotype inflammatory breast cancer (IBC) versus non-IBC invasive ductal carcinoma (IDC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_provenance.
- NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion evidence source_evidence_literature NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_provenance.
- NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion SIO_000772 24790704 NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_provenance.
- NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion wasDerivedFrom befree-2016 NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_provenance.
- NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_assertion wasGeneratedBy ECO_0000203 NP1178933.RApNdbv7U7KqT2Tg3bI4m2GXYIWWFr06TO7KYSUd-fhCE130_provenance.